ID

43903

Beschrijving

Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM; ODM derived from: https://clinicaltrials.gov/show/NCT02301806

Link

https://clinicaltrials.gov/show/NCT02301806

Trefwoorden

Versies (2)
  1. 29-06-16 29-06-16 -
  2. 20-09-21 20-09-21 -
Geüploaded op

20 september 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Type 2 Diabetes NCT02301806

Engels

Eligibility Type 2 Diabetes NCT02301806

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
provision of informed consent before any study specific procedures
Beschrijving

Informed consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
type ii diabetes who have inadequate glycaemic control (6.5%≦hba1c＜9.0%)
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent Poor glycemic control

Datatype

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0342299
age from 20 to 80 years old
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
no history of using any antihyperglycemic drugs
Beschrijving

Hypoglycemic Agents Not used

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020616
UMLS CUI [1,2]
C0445107
no history of cardiovascular complications
Beschrijving

Cardiac complication Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0161816
UMLS CUI [1,2]
C0332197
no treatment or treatment with stable doses of lipid-lowering, antihypertensive, and antiplatelet agents for at least 3 months prior to randomization
Beschrijving

Antilipemic agent Therapeutic procedure Absent | Antilipemic agent Therapeutic procedure Dosage Stable | Antihypertensive Agents Therapeutic procedure Absent | Antihypertensive Agents Therapeutic procedure Dosage Stable | Antiplatelet Agents Therapeutic procedure Absent | Antiplatelet Agents Therapeutic procedure Dosage Stable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0086440
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0086440
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0178602
UMLS CUI [2,4]
C0205360
UMLS CUI [3,1]
C0003364
UMLS CUI [3,2]
C0087111
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C0003364
UMLS CUI [4,2]
C0087111
UMLS CUI [4,3]
C0178602
UMLS CUI [4,4]
C0205360
UMLS CUI [5,1]
C0085826
UMLS CUI [5,2]
C0087111
UMLS CUI [5,3]
C0332197
UMLS CUI [6,1]
C0085826
UMLS CUI [6,2]
C0087111
UMLS CUI [6,3]
C0178602
UMLS CUI [6,4]
C0205360
4.5 % ≤ fasting fmd at baseline < 8.0 %
Beschrijving

Diet therapy Fasting Imitation

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012159
UMLS CUI [1,2]
C0015663
UMLS CUI [1,3]
C3826143
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
・type i diabetes
Beschrijving

Diabetes Mellitus, Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011854
pregnancy
Beschrijving

Pregnancy

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
liver disease (hepatic enzymes more than three times the upper limit of normal ranges)
Beschrijving

Liver disease Elevated liver enzymes

Datatype

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0235996
impairared kidney function (serum crearinine greater than 1.3 mg/dl in men, 1.2 mg/dl in women)
Beschrijving

Renal Insufficiency | Creatinine measurement, serum | Gender

Datatype

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0201976
UMLS CUI [3]
C0079399
cigarette smokers
Beschrijving

Cigarette smoker

Datatype

boolean

Alias
UMLS CUI [1]
C0337667
contraindications to glimepiride and sitagliptin
Beschrijving

Medical contraindication glimepiride | Medical contraindication sitagliptin

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0061323
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C1565750
active proliferative diabetic retinopathy
Beschrijving

Proliferative diabetic retinopathy

Datatype

boolean

Alias
UMLS CUI [1]
C0154830
Terug naar het begin van de pagina

Similar models

Eligibility Type 2 Diabetes NCT02301806

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Informed consent
Item
provision of informed consent before any study specific procedures
boolean
C0021430 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent Poor glycemic control
Item
type ii diabetes who have inadequate glycaemic control (6.5%≦hba1c＜9.0%)
boolean
C0011860 (UMLS CUI [1,1])
C0342299 (UMLS CUI [1,2])
Age
Item
age from 20 to 80 years old
boolean
C0001779 (UMLS CUI [1])
Hypoglycemic Agents Not used
Item
no history of using any antihyperglycemic drugs
boolean
C0020616 (UMLS CUI [1,1])
C0445107 (UMLS CUI [1,2])
Cardiac complication Absent
Item
no history of cardiovascular complications
boolean
C0161816 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Antilipemic agent Therapeutic procedure Absent | Antilipemic agent Therapeutic procedure Dosage Stable | Antihypertensive Agents Therapeutic procedure Absent | Antihypertensive Agents Therapeutic procedure Dosage Stable | Antiplatelet Agents Therapeutic procedure Absent | Antiplatelet Agents Therapeutic procedure Dosage Stable
Item
no treatment or treatment with stable doses of lipid-lowering, antihypertensive, and antiplatelet agents for at least 3 months prior to randomization
boolean
C0086440 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0086440 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0205360 (UMLS CUI [2,4])
C0003364 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0003364 (UMLS CUI [4,1])
C0087111 (UMLS CUI [4,2])
C0178602 (UMLS CUI [4,3])
C0205360 (UMLS CUI [4,4])
C0085826 (UMLS CUI [5,1])
C0087111 (UMLS CUI [5,2])
C0332197 (UMLS CUI [5,3])
C0085826 (UMLS CUI [6,1])
C0087111 (UMLS CUI [6,2])
C0178602 (UMLS CUI [6,3])
C0205360 (UMLS CUI [6,4])
Diet therapy Fasting Imitation
Item
4.5 % ≤ fasting fmd at baseline < 8.0 %
boolean
C0012159 (UMLS CUI [1,1])
C0015663 (UMLS CUI [1,2])
C3826143 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
・type i diabetes
boolean
C0011854 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Liver disease Elevated liver enzymes
Item
liver disease (hepatic enzymes more than three times the upper limit of normal ranges)
boolean
C0023895 (UMLS CUI [1,1])
C0235996 (UMLS CUI [1,2])
Renal Insufficiency | Creatinine measurement, serum | Gender
Item
impairared kidney function (serum crearinine greater than 1.3 mg/dl in men, 1.2 mg/dl in women)
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Cigarette smoker
Item
cigarette smokers
boolean
C0337667 (UMLS CUI [1])
Medical contraindication glimepiride | Medical contraindication sitagliptin
Item
contraindications to glimepiride and sitagliptin
boolean
C1301624 (UMLS CUI [1,1])
C0061323 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C1565750 (UMLS CUI [2,2])
Proliferative diabetic retinopathy
Item
active proliferative diabetic retinopathy
boolean
C0154830 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial